Clinical and biologic factors related to oral implant failure: a 2-year follow-up study.
The purpose of this study is to evaluate urinary biomarkers of bone formation and resorption as predictive factors for oral implant failure, and to contribute to the knowledge of factors related to oral implant failure. A total of 93 patients between 18 and 85 years old, with an indication of oral implant, were eligible in this 2-year prospective, open, and nonrandomized study. Patients who had bone graft before implantation or presented with prosthetic difficulties (implant-to-crown ratio < 1, and/or unfavorable intermaxillary space) were excluded. All patients received either Frialit-2 (Friadent, Mannheim, Germany), cylinder, or screwed implants or IMZ Twin Plus (Friadent), cylinder implants, with FRIOS (Friadent) titanium coating. Serum osteocalcin, and urinary pyridinoline and deoxypyridinoline were measured, together with bone density at implant location. The primary endpoint (implant failure) was the implant removal (radiographic evidence of peri-implant bone loss and/or pockets). Factors related to implant failure were analyzed using multilevel logistic regression models to consider within-patient effects. Of the 93 patients included, 61% were female, and 16% were current smokers. A total of 266 oral implants were placed and analyzed, with a mean number of 3.1 implants by patient. Eleven and 15% of bone locations scored at D1 and D4, respectively, for the Misch bone density scoring. The majority of implants (72%) were placed more than 3 months after tooth extraction, using a Frialit-2 system in 73% of cases. The mean of osteocalcin was 17.3 (+/-9.4) ng/L; those of pyridinoline and deoxypyridinoline were 33.2 (+/-15.8) and 10.2 (+/-11.9) mmol per creatinine mmol, respectively. At one-year, 95.5% (95% confidence interval 92.5-97.5) of implants have not been removed. One year later, no further implant failed. In both univariate and multivariate analysis, osteocalcin, pyridinoline, and deoxypyridinoline were not significant predictive factors of oral implant failure. In multilevel logistic regression analysis, only tobacco consumption and single-tooth replacement or removable prosthesis were independent and significant predictive factors of oral implant failure. Serum osteocalcin, and urinary pyridinoline and deoxypyridinoline were not predictive of oral implant failure in this study. These results suggest that oral implants are more likely to fail for posterior single-tooth replacements and removable prostheses rather than for complete edentulous fixed bridgeworks or overdentures. Tobacco smoking has been identified as a major risk factor of oral implant failure.
Moheng
Patrick
P
Center of Dental Implantology, Ambroise Pare Hospital, Rue d'Iena, 13291 Marseilles Cedex 6, France. p.moheng@ch-ambroisepare.fr
Feryn
Jean-Marc
JM
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D016301:Alveolar Bone Loss / Q000209:etiology; D000596:Amino Acids / Q000652:urine; D015415:Biomarkers / Q000652:urine; D015519:Bone Density / Q000502:physiology; D001862:Bone Resorption / Q000652:urine*; D003404:Creatinine / Q000652:urine; D015921:Dental Implants; D017267:Dental Prosthesis Design; D019232:Dental Restoration Failure; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008875:Middle Aged; D015675:Osteocalcin / Q000652:urine; D010012:Osteogenesis / Q000502:physiology*; D010514:Periodontal Pocket / Q000209:etiology; D011446:Prospective Studies; D012907:Smoking
D000596:Amino Acids; D015415:Biomarkers; D015921:Dental Implants; D015675:Osteocalcin; C015484:pyridinoline; C036020:deoxypyridinoline; D003404:Creatinine